• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Genetics remains at top of academic research

Genetics remains at top of academic research

March 11, 2011
CenterWatch Staff

Genetics is still the hottest area of scientific research, a decade since the mapping of the human genome, despite slow progress in translating discoveries into new medical treatments, according to a report in Reuters.

A Reuters Science Watch survey found seven of the top 13 researchers in 2010 worked in genetics, with Eric Lander of the Broad Institute of Harvard and MIT as the world's "hottest" researcher. Lander's work covered genetic mapping and human disease, including lung cancer.

The annual survey looks at research across different scientific disciplines and uses the Web of Science database to see which papers published in the last two years are cited the most by other scientists.

Ten years after the first full sequence of the human genome was published, early expectations of rapid breakthroughs in fighting disease have proved misplaced.

But academic interest has not slackened, and scientists remain hopeful that the tsunami of information unlocked by genomics, or the study of genetic sequences, will eventually yield big dividends.

One early success, in fact, is the FDA approval for Human Genome Sciences’ lupus drug Benlysta, the first drug derived from genomics to win marketing clearance.

Three of the hottest researchers in the latest Science Watch survey came from Iceland's Decode Genetics, which pioneered deeper understanding of the relationships between genes and common diseases but filed for bankruptcy protection in 2009 before re-emerging as a private business last year.

Outside the field of genetics, Andre Geim at the University of Manchester made a third consecutive appearance on the Science Watch hot list, this time in his capacity as a Nobel Laureate.  Yang Yang of the University of California, Los Angeles, also made the hot list for research on polymer solar cells.

Upcoming Events

  • 06Jun

    Gene & Cell Therapy Regulation: Comparability and Other New Developments

  • 07Jun

    Developing World-Class SOPs: Optimizing Quality and Compliance

  • 08Jun

    Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing